|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.850 EUR | -2.04% |
|
-0.77% | +6.65% |
| 04-18 | Evrofarma SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-17 | Evrofarma FY 2025 net profit at EUR 3.5 million, up 55% YoY | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 4 | 4 | 4 |
| Spread/Res. | -3.75% | -3.75% | -3.75% |
| Spread/Supp. | +2.39% | +20.31% | +24.19% |
| Support | 3.76 | 3.2 | 3.1 |
- Stock Market
- Stocks
- EVROF Stock
- Charts Evrofarma SA
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
